This is a general collection of COVID-19 data deposited in the Harvard Dataverse repository. The list in this collection is maintained by the Harvard Dataverse data curation team (IQSS and Harvard Library). Researchers who deposit their related data into Harvard Dataverse will have their data linked to this collection, to increase discoverability of their data. Please use the contact link if you have any questions about this collection.
Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

81 to 90 of 55,989 Results
18_HPRIME_Form18_Cardiac Study v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 26.7 KB - MD5: f8654e684afdee3175be4605d04e3d0d
19_HPRIME_Form19_withdrawal of consent v3.0__20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 25.0 KB - MD5: eb4281dab5a858966ee4167a958de8ab
1_HPRIME_Form1_screening_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 37.6 KB - MD5: 6e13e2656d018873b204ae03e989451a
20_grade 4 laboratory events v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 27.3 KB - MD5: 1a2816e4765f9be8cef042779def518a
2_HPRIME_Form2_eligibility_v3.0__20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 31.0 KB - MD5: 3e580f57a04dda425e8d44f484d5c512
3_HPRIME_Form3_baseline_v3.0__20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 43.2 KB - MD5: 4df2d17f666f52d830fb7a730b63e564
4_HPRIME_Form4_randomisation_v3.0__20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 28.1 KB - MD5: c1b84c9bd90938b80d02f9fe283584d3
5_HPRIME_Form5_medication_v3.0__20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 25.6 KB - MD5: 90ae337d2fa1586e18bb3913bc1dcac5
6_HPRIME_Form6_follow-up_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 84.1 KB - MD5: fedf535507f6a8a23b4f80b065a8fa4b
7_HPRIME_Form7_grade 3or4 AE_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 26.5 KB - MD5: 22f9fdbb38742456759877bfa49ed909
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.